NCT03890016 (LAT) is a clinical trial of 20'Whole Blood ClottingTest (WBCT) in Coagulation Defect, sponsored by Appu Suseel.

Who is sponsoring NCT03890016?

NCT03890016 is sponsored by Appu Suseel.

What drugs are being tested in NCT03890016?

Interventions in NCT03890016: 20'Whole Blood ClottingTest (WBCT), Modified Lee and White (MLW) Method Clotting Time.

What condition does NCT03890016 study?

NCT03890016 studies Coagulation Defect, Snake Bites.

Is NCT03890016 still recruiting?

NCT03890016 is currently completed. Last updated 17 August 2020.

Last reviewed 2020-08-17 · How we verify

NCT03890016: LAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims

Completed Last updated 17 August 2020

What this trial tests

trial testing 20'Whole Blood ClottingTest (WBCT) in Coagulation Defect in 230 participants. Completed in 30 June 2020.

Timeline

1 May 2019

Primary endpoint
31 May 2020

30 June 2020

Quick facts

Lead sponsor	Appu Suseel
Status	Completed
Study type	OBSERVATIONAL
Enrollment	230
Start date	1 May 2019
Primary completion	31 May 2020
Estimated completion	30 June 2020
Sites	1 location across India

Drugs / interventions tested

20'Whole Blood ClottingTest (WBCT)
Modified Lee and White (MLW) Method Clotting Time

Conditions studied

Coagulation Defect — all drugs for Coagulation Defect →
Snake Bites — all drugs for Snake Bites →

Sponsor

Appu Suseel

Who can join

Eligibility, any sex, with Coagulation Defect or Snake Bites. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

20 minute Whole Blood Clotting Test(20'WBCT) recommended by World Health Organisation guidelines is probably the most routinely employed bed side screening tool in the country. The Modified Lee and White (MLW) method gives a value which when performed serially gives a trend in clotting time which the investigators hypothesise to be a better tool in serially assessing the victim compared to the 20'WBCT. The investigators propose that delayed reading of both MLW and 20'WBCT to check for clot stability at 30 minutes also provides added information in management of snake bite victims.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing modified Lee and White method against 20-minute whole blood clotting test as bedside coagulation screening test in snake envenomation victims.
Suseel A, Abraham SV, Paul S, Tomy MML, et al · · 2023 · cited 4× · PMID 37342654 · DOI 10.1590/1678-9199-jvatitd-2022-0088

Verify or expand the search:

Other recruiting trials for Coagulation Defect

Currently open trials in the same condition.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03890016 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Appu Suseel
Last refreshed: 17 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing